CLEC1B and viral infectious disease: In the prophylactic model (blue bars, Fig 4C), mice were injected with CLEC2.Fc (100 μg) at 60 min before intravenous inoculation of SARS‐CoV‐2 (lower blue bar, Fig 4C), followed by a second dose of CLEC2.Fc (100 μg) at day 3 post‐virus infection (upper blue bar, Fig 4C).